Attending the breast screening programme after breast cancer treatment: A population-based study

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 968-972

  De Munck, Linda ^a   Kwast, Annemiek ^a,b   Reiding, Dick ^c   de Bock, Geertruida H ^d   Otter, Renée ^a,d   Willemse, Pax H B ^d   Siesling, Sabine ^a,e  

^a Department of Cancer Registry and Research   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c National Cancer Screening Programme North   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Attendance; Breast cancer; Follow up; Interval tumour; Long term survival; Screen detected; Screening programme

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SCREENING; CANCER THERAPY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL;

ATTENDANCE; BREAST CANCER; FOLLOW-UP; INTERVAL TUMOUR; LONG-TERM SURVIVAL; SCREEN-DETECTED; SCREENING PROGRAMME;

AGED; BREAST NEOPLASMS; CANADA; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NETHERLANDS; PATIENT PARTICIPATION; PROGNOSIS; PROGRAM EVALUATION;

EID: 84888289830     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.09.003     Document Type: Article

References (23)

1. Comprehensive Cancer Centre the Netherlands. [accessed 26.08.13]. http://www.cancerregistry.nl/.
2. Fracheboud J., de Koning H.J., Boer R., Groenewoud J.H., Verbeek A.L., Broeders M.J., et al. Nationwide breast cancer screening programme fully implemented in the Netherlands. Breast 2001, 10:6-11.
3. de Bock G.H., Bonnema J., van der Hage J., Kievit J., van de Velde C.J.H. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol 2004, 22:4010-4018.
4. Grunfeld E., Levine M.N., Julian J.A., Coyle D., Szechtman B., Mirsky D., et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 2006, 24:848-855.
5. Montgomery D.A., Krupa K., Cooke T.G. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 2007, 97:1632-1641.
6. Kimman M.L., Voogd A.C., Dirksen C.D., Falger P., Hupperets P., Keymeulen K., et al. Follow-up after curative treatment for breast cancer: why do we still adhere to frequent outpatient clinic visits?. Eur J Cancer 2007, 43:647-653.
7. Sheppard C. Breast cancer follow-up: literature review and discussion. Eur J Oncol Nurs 2007, 11:340-347.
8. Grunfeld E. Optimizing follow-up after breast cancer treatment. Curr Opin Obstet Gynecol 2009, 21:92-96.
9. Kimman M.L., Bloebaum M.M., Dirksen C.D., Houben R.M., Lambin P., Boersma L.J. Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer. BMC Cancer 2010, 30(10):174.
10. van Hezewijk M., Ranke G.M.C., van Nes J.G.H., Stiggelbout A.M., de Bock G.H., van de Velde C.J.H. Patients' needs and preferences in routine follow-up for early breast cancer; an evaluation of the changing role of the nurse practitioner. Eur J Surg Oncol 2011, 37:765-773.
11. National Breast Cancer Organization of the Netherlands Guideline breast cancer 2008 2008, http://www.oncoline.nl [accessed 04.04.12].
12. National Breast Cancer Organization of the Netherlands Guideline breast cancer 2012 2012, http://www.oncoline.nl [accessed 20.10.12].
13. de Munck L., Schaapveld M., Siesling S., Wesseling J., Voogd A.C., Tjan-Heijnen V.C.G., et al. Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands. Breast Cancer Res Treat 2011, 129:229-233.
14. van der Leij F., Elkhuizen P.H.M., Bartelink H., van de Vijver M.J. Predictive factors for local recurrence in breast cancer. Semin Radiat Oncol 2012, 22:100-107.
15. Grandjean I., Kwast A.B.G., de Vries H., Klaase J., Schoevers W.J., Siesling S. Evaluation of the adherence to follow-up care guidelines for women with breast cancer. Eur J Oncol Nurs 2012, 16:281-285.
16. de Bock G.H., Bonnema J., Zwaan R.E., van de Velde C.J.H., Kievit J., Stiggelbout A.M. Patient's needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer 2004, 90:1144-1150.
17. Jacobs H.J.M., van Dijck J.A.A.M., de Kleijn E.M.H.A., Kiemeney L.A.L.M., Verbeek A.L.M. Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: a simulation study. Ann Oncol 2001, 12:1107-1113.
18. Allen A. The meaning of the breast cancer follow-up experience for the women who attend. Eur J Oncol Nurs 2002, 6:155-161.
19. Kwast A.B.G., Drossaert C.H.C., Siesling S. Breast cancer follow-up: from the perspective of health professionals and patients. Eur J Cancer Care 2013, 10.1111/ecc.12094.
20. Otter R. Richtlijnen voor diagnostiek en behandeling van premaligne en maligne aandoeningen in de IKN-regio 2003, Integraal Kankercentrum Noord-Nederland, Groningen.
21. National Breast Cancer Organization of the Netherlands Guideline breast cancer 2005 2005, http://www.oncoline.nl [accessed 04.04.12].
22. Zonderland H.M., Tuut M.K., den Heeten G.J., van Asperen C.J., de Bock G.H., Rutgers E.J.Th., et al. Richtlijn 'screening en diagnostiek van het mammacarcinoom' (heziening). Ned Tijdschr Geneeskd 2008, 152:2336-2339.
23. Shaheen R., Schimmelpenninck C.A., Stoddart L., Raymond H., Slanetz P.J. Spectrum of diseases presenting as architectural distortion on mammography: multimodality radiologic imaging with pathologic correlation. Semin Ultrasound CT MRI 2011, 32:351-362.